These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 2174032)
21. Dapsone-induced haemolytic anaemia and agranulocytosis in a patient with normal glucose-6-phosphate-dehydrogenase activity. Figueiredo MS; Pinto BO; Zago MA Acta Haematol; 1989; 82(3):144-5. PubMed ID: 2510435 [TBL] [Abstract][Full Text] [Related]
22. Dapsone induced motor polyneuropathy. Jacob AJ; Rajendran A; Menezes J; Vaz M Southeast Asian J Trop Med Public Health; 1992 Jun; 23(2):341-3. PubMed ID: 1332194 [No Abstract] [Full Text] [Related]
24. Dapsone-induced hemolytic anemia: effect of dapsone hydroxylamine on sulfhydryl status, membrane skeletal proteins and morphology of human and rat erythrocytes. McMillan DC; Simson JV; Budinsky RA; Jollow DJ J Pharmacol Exp Ther; 1995 Jul; 274(1):540-7. PubMed ID: 7616443 [TBL] [Abstract][Full Text] [Related]
25. Cherry red spot in sialidosis (mucolipidosis type I). Heroman JW; Rychwalski P; Barr CC Arch Ophthalmol; 2008 Feb; 126(2):270-1. PubMed ID: 18268224 [No Abstract] [Full Text] [Related]
26. A clinicopathological study of multidrug therapy in borderline tuberculoid leprosy. Kar PK; Arora PN; Ramasastry CV; Dhaka RS J Indian Med Assoc; 1994 Oct; 92(10):336-7. PubMed ID: 7822849 [TBL] [Abstract][Full Text] [Related]
27. Role of lipid peroxidation in dapsone-induced hemolytic anemia. McMillan DC; Jensen CB; Jollow DJ J Pharmacol Exp Ther; 1998 Dec; 287(3):868-76. PubMed ID: 9864266 [TBL] [Abstract][Full Text] [Related]
28. Dapsone-induced hemolytic anemia: role of glucose-6-phosphate dehydrogenase in the hemolytic response of rat erythrocytes to N-hydroxydapsone. Grossman S; Budinsky R; Jollow D J Pharmacol Exp Ther; 1995 May; 273(2):870-7. PubMed ID: 7752092 [TBL] [Abstract][Full Text] [Related]
29. Role of dapsone hydroxylamine in dapsone-induced hemolytic anemia. Grossman SJ; Jollow DJ J Pharmacol Exp Ther; 1988 Jan; 244(1):118-25. PubMed ID: 3335994 [TBL] [Abstract][Full Text] [Related]
30. Haemolytic anaemia during treatment of leprosy with diaminodiphenylsulphone by mouth. RAMANUJAM K; SMITH M Lancet; 1951 Jan; 1(6645):21-2. PubMed ID: 14795753 [No Abstract] [Full Text] [Related]
31. Clinical and electroneurophysiological assessment of leprosy patients on dapsone monotherapy--a two year follow-up study. Rao SP; Taori GM; Desikan KV; Nayar S Indian J Lepr; 1995; 67(2):167-76. PubMed ID: 8537705 [TBL] [Abstract][Full Text] [Related]
32. Effect of drug treatment on electroneurological measures of peripheral nerve function in leprosy patients. Mendis S; Somasiri KG; Chularatna W Ceylon Med J; 1993 Dec; 38(4):174-7. PubMed ID: 8143332 [TBL] [Abstract][Full Text] [Related]
33. The neurotoxicity of dapsone. Daneshmend TK Adverse Drug React Acute Poisoning Rev; 1984; 3(1):43-58. PubMed ID: 6091422 [No Abstract] [Full Text] [Related]
34. Macular cherry-red spot and corneal haze in sialidosis (mucolipidosis type 1). Goldberg MF Arch Ophthalmol; 2008 Dec; 126(12):1778; author reply 1778. PubMed ID: 19064869 [No Abstract] [Full Text] [Related]
38. Primary drug resistance to both rifampicin and dapsone in a paucibacillary leprosy patient. Koranne RV; Srivastava G Indian J Lepr; 1988 Jan; 60(1):90-2. PubMed ID: 3060548 [TBL] [Abstract][Full Text] [Related]